SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-24-000506
Filing Date
2024-05-15
Accepted
2024-05-15 07:53:57
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q novaccess20240331_10q.htm   iXBRL 10-Q 1295980
2 EXHIBIT 31.1 ex_671674.htm EX-31.1 8178
3 EXHIBIT 31.2 ex_671675.htm EX-31.2 8044
4 EXHIBIT 32.1 ex_671676.htm EX-32.1 3579
  Complete submission text file 0001185185-24-000506.txt   7298571

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20240331.xsd EX-101.SCH 52914
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xsnx-20240331_cal.xml EX-101.CAL 26411
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20240331_def.xml EX-101.DEF 275951
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20240331_lab.xml EX-101.LAB 455107
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20240331_pre.xml EX-101.PRE 284910
65 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20240331_10q_htm.xml XML 1175551
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

IRS No.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-29621 | Film No.: 24947213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)